A Stakeholder Interchange convened in Los Angeles, California, by The American Journal of Managed Care explores the treatment ...

For more than a year, Diane Hunter, now 72, had been experiencing vague symptoms—pain in her spine and hips, nausea, ...

Sequencing treatment for patients with relapsed or refractory multiple myeloma depends on the patient’s disease and history, explained Lisa Hwa Christenson, DNP, APRN, CNP, associate professor of ...

For the first time in more than a decade, a new frontline treatment for an incurable blood cancer is being added to the ...

MM survival rates have improved with the introduction of novel agents. Treatment of MM within the first year is associated with improved survival. New research has concluded that, despite more ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA ;Ryan Haumschild, PharmD, MS, MBA;Faith Davies, MD;Shachar Peles, MD;Sagar Lonial MD, FACP Panelists discuss how ...

This one-hour on-demand video learning module features a pair of expert multidisciplinary hematology providers who specialize in the treatment of multiple myeloma. Their discussion includes a didactic ...

In patients with symptomatic multiple myeloma, renal impairment leading to acute kidney injury (AKI) is a common complication ...